Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
1.930
+0.050 (2.66%)
Mar 9, 2026, 2:21 PM EDT - Market open
CELZ Revenue
Creative Medical Technology Holdings had revenue of $6.00K in the twelve months ending September 30, 2025, down -45.45% year-over-year. In the year 2024, Creative Medical Technology Holdings had annual revenue of $11.00K with 22.22% growth.
Revenue (ttm)
$6.00K
Revenue Growth
-45.45%
P/S Ratio
1,095.00
Revenue / Employee
$1,500
Employees
4
Market Cap
6.74M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evogene | 8.02M |
| Moolec Science | 7.83M |
| Immuron | 4.99M |
| XTL Biopharmaceuticals | 968.00K |
| Can-Fite BioPharma | 560.00K |
| Aprea Therapeutics | 488.24K |
CELZ News
- 7 weeks ago - Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain - GlobeNewsWire
- 2 months ago - Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative - GlobeNewsWire
- 2 months ago - Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point - GlobeNewsWire
- 3 months ago - Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201 - GlobeNewsWire
- 4 months ago - Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits - GlobeNewsWire
- 4 months ago - Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds - GlobeNewsWire
- 4 months ago - Creative Medical Technology Holdings Issues Letter to Shareholders - GlobeNewsWire
- 5 months ago - Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs - GlobeNewsWire